Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1575596-29-0
Purity
95%
Rilzabrutinib (PRN1008) is a reversible covalent and selective inhibitor of Bruton’s Tyrosine Kinase (BTK), with an IC50 of 1.5 nM.
Properties
Name
Rilzabrutinib (PRN1008)
Smiles
CC(C)(/C=C(\C#N)/C(=O)N1CCC[C@H](C1)N2N=C(C=3C=CC(OC=4C=CC=CC4)=CC3F)C=5C(N)=NC=NC25)N6CCN(CC6)C7COC7
Targets
Please log in to see this information
Target name
Target pX
Target action
doi
SDS
PNR 1008 | PRN1008 | rilzabrutinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$185
2 mg
$277
5 mg
$554
10 mg
$960
15 mg
$1166
20 mg
$1256
25 mg
$1551
30 mg
$1847
35 mg
$2142
40 mg
$2437
45 mg
$2733
50 mg
$3028
75 mg
$4431
100 mg
$POA
Quantity
1
Total amount
$ 554
PNR 1008 | PRN1008 | rilzabrutinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:1575596-29-0
0
CAS:1575591-66-0
0